Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine.

Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection.

Continued zidovudine or didanosine for human immunodeficiency virus infection.

Adrenocortical function in Nigerians with human immunodeficiency virus infection.

Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-alpha and zidovudine.

A survey of zidovudine use in pregnant women with human immunodeficiency virus infection.

Multiple-dose pharmacokinetics of oral zidovudine in hemophilia patients with human immunodeficiency virus infection.

Human immunodeficiency virus infection in children.

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

Combination treatment with azidothymidine and granulocyte colony-stimulating factor in children with human immunodeficiency virus infection.

Cardiac surgery in patients with human immunodeficiency virus infection: indications and results.

Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner.

Zidovudine in the treatment of human immunodeficiency virus disease.

Structure and function of the human immunodeficiency virus type 1.

Children and Human Immunodeficiency Virus Infection: Opportunities and challenges.

Clinical Characteristics and Lung Function in Older Children Vertically Infected With Human Immunodeficiency Virus in Malawi.

Gonadal function and reproductive health in women with human immunodeficiency virus infection.

A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group.

A pilot study of low-dose zidovudine in human immunodeficiency virus infection.

Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection.

Retinal toxicity in human immunodeficiency virus-infected children treated with 2',3'-dideoxyinosine.

Human immunodeficiency virus infection in children--a guide for families.

A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.

BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine.

Suggest Documents

Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection.

Continued zidovudine or didanosine for human immunodeficiency virus infection.

Adrenocortical function in Nigerians with human immunodeficiency virus infection.

Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-alpha and zidovudine.

A survey of zidovudine use in pregnant women with human immunodeficiency virus infection.

Multiple-dose pharmacokinetics of oral zidovudine in hemophilia patients with human immunodeficiency virus infection.

Human immunodeficiency virus infection in children.

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

Combination treatment with azidothymidine and granulocyte colony-stimulating factor in children with human immunodeficiency virus infection.

Cardiac surgery in patients with human immunodeficiency virus infection: indications and results.

Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner.

Zidovudine in the treatment of human immunodeficiency virus disease.

Structure and function of the human immunodeficiency virus type 1.

Children and Human Immunodeficiency Virus Infection: Opportunities and challenges.

Clinical Characteristics and Lung Function in Older Children Vertically Infected With Human Immunodeficiency Virus in Malawi.

Gonadal function and reproductive health in women with human immunodeficiency virus infection.

A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group.

A pilot study of low-dose zidovudine in human immunodeficiency virus infection.

Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection.

Retinal toxicity in human immunodeficiency virus-infected children treated with 2',3'-dideoxyinosine.

Human immunodeficiency virus infection in children--a guide for families.

A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.

BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine.

Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine.

Recommend Documents

Follow Us